Unique ID issued by UMIN | UMIN000019259 |
---|---|
Receipt number | R000022102 |
Scientific Title | Molecular biological analysis of the factors involved in the diagnosis, therapeutic effect prediction and prognosis of biliary tract and pancreatic tumor |
Date of disclosure of the study information | 2015/10/10 |
Last modified on | 2022/02/23 14:46:26 |
Molecular biological analysis of the factors involved in the diagnosis, therapeutic effect prediction and prognosis of biliary tract and pancreatic tumor
Molecular biological analysis of biliary tract and pancreatic tumor
Molecular biological analysis of the factors involved in the diagnosis, therapeutic effect prediction and prognosis of biliary tract and pancreatic tumor
Molecular biological analysis of biliary tract and pancreatic tumor
Japan |
biliary tract and pancreatic tumor
Hepato-biliary-pancreatic medicine |
Malignancy
NO
To develop new methods of diagnosis, chemosensitivity prediction, and prognosis prediction of biliary tract and pancreatic tumor by analyzing molecular biological factors using surgical specimens, EUS-FNA samples,and peripheral blood samples.
Others
To develop new methods of diagnosis, chemosensitivity prediction, and prognosis prediction
Diagnostic method: the relationship between the analyzing factors and pathological diagnosis
Chemosensitivity: the relationship between the analyzing factors and the chemosensitivity evaluated by RECIST guidelines version 1.1
Prognosis: the relationship between the analyzing factors and overall survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Maneuver |
Blood collection of peripheral blood
20 | years-old | <= |
Not applicable |
Male and Female
Biliary tract and pancreatic tumor patients, biliary tract and pancreatic inflammatory disease patients, multiple sclerosis patients, and healthy volunteers.
Following conditions are needed for inclusion;
(1) more than 20 years old.
(2) the consent of participation in this study is obtained as a writing document from participant or the family.
Patients who are clearly expected to develop fatal complications by blood sampling.
500
1st name | |
Middle name | |
Last name | Kensuke Kubota |
Yokohama City University Graduate School of Medicine
Department of Oncology
3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan
+81-45-787-2640
kubotak@yokohama-cu.ac.jp
1st name | |
Middle name | |
Last name | Shingo Kato |
Yokohma City University Hospital
Department of Gastroenterology and Hepatology
3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan
+81-45-787-2640
shin800m@yokohama-cu.ac.jp
Yokohma City University Hospital
The Japan Society for the Promotion of Science (JSPS)
NO
2015 | Year | 10 | Month | 10 | Day |
Unpublished
Completed
2015 | Year | 10 | Month | 10 | Day |
2015 | Year | 07 | Month | 15 | Day |
2015 | Year | 10 | Month | 13 | Day |
2020 | Year | 07 | Month | 05 | Day |
2015 | Year | 10 | Month | 07 | Day |
2022 | Year | 02 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022102
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |